• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬血管肉瘤作为人类血管肉瘤药物发现研究的潜在非啮齿类动物模型。

Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.

作者信息

Heishima Kazuki, Aketa Naohiko, Heishima Mizuki, Kawachi Asuka

机构信息

Institute for Advanced Study (GUiAS), Gifu University, Gifu, Japan.

Center for One Medicine Innovative Translational Research (COMIT), Gifu University, Gifu, Japan.

出版信息

Front Oncol. 2023 Dec 7;13:1250766. doi: 10.3389/fonc.2023.1250766. eCollection 2023.

DOI:10.3389/fonc.2023.1250766
PMID:38130992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10733437/
Abstract

Since the domestication of dogs 10,000 years ago, they have shared their living environment with humans and have co-evolved. The breeding process that dogs have undergone in only a few centuries has led to a significant accumulation of specific genetic alterations that could induce particular diseases in certain breeds. These canine diseases are similar to what is found in humans with several differences; therefore, comparing such diseases occurring in humans and dogs can help discover novel disease mechanisms, pathways, and causal genetic factors. Human angiosarcoma (AS) and canine hemangiosarcoma (HSA), which are sarcomas originating from endothelium, are examples of diseases shared between humans and dogs. They exhibit similar characteristics and clinical behaviors, although with some critical differences resulting from evolution. In this review, we will describe the similarities and differences in terms of clinical and molecular characteristics between human AS and canine HSA, and discuss how these similarities and differences can be applied to advance the treatment of these diseases.

摘要

自一万年前狗被驯化以来,它们就与人类共享生活环境并共同进化。狗在短短几个世纪内经历的育种过程导致特定基因改变大量积累,这些改变可能在某些品种中引发特定疾病。这些犬类疾病与人类疾病有一些差异但也有相似之处;因此,比较人类和狗身上发生的此类疾病有助于发现新的疾病机制、途径和致病基因因素。人类血管肉瘤(AS)和犬类血管肉瘤(HSA)均起源于内皮细胞的肉瘤,是人类和狗共有的疾病实例。它们表现出相似的特征和临床行为,尽管进化导致了一些关键差异。在本综述中,我们将描述人类AS和犬类HSA在临床和分子特征方面的异同,并讨论如何利用这些异同来推进这些疾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/075a/10733437/43e90784a5f8/fonc-13-1250766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/075a/10733437/fe9dbc3c8b04/fonc-13-1250766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/075a/10733437/43e90784a5f8/fonc-13-1250766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/075a/10733437/fe9dbc3c8b04/fonc-13-1250766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/075a/10733437/43e90784a5f8/fonc-13-1250766-g002.jpg

相似文献

1
Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans.犬血管肉瘤作为人类血管肉瘤药物发现研究的潜在非啮齿类动物模型。
Front Oncol. 2023 Dec 7;13:1250766. doi: 10.3389/fonc.2023.1250766. eCollection 2023.
2
Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.比较基因组学揭示了犬血管肉瘤和人类血管肉瘤的共同突变特征。
Mol Cancer Res. 2019 Dec;17(12):2410-2421. doi: 10.1158/1541-7786.MCR-19-0221. Epub 2019 Sep 30.
3
Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma.犬血管肉瘤的比较病理学认识和前瞻性研究方法。
Res Vet Sci. 2024 Feb;167:105120. doi: 10.1016/j.rvsc.2023.105120. Epub 2023 Dec 23.
4
MicroRNA-214 and MicroRNA-126 Are Potential Biomarkers for Malignant Endothelial Proliferative Diseases.微小RNA-214和微小RNA-126是恶性内皮增殖性疾病的潜在生物标志物。
Int J Mol Sci. 2015 Oct 23;16(10):25377-91. doi: 10.3390/ijms161025377.
5
Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.犬血管肉瘤的分子亚型与人类血管肉瘤具有相似性。
PLoS One. 2020 Mar 25;15(3):e0229728. doi: 10.1371/journal.pone.0229728. eCollection 2020.
6
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.犬脾脏血管肉瘤(血管肉瘤)的基因组景观在患者内部和之间存在广泛的异质性。
PLoS One. 2022 Jul 22;17(7):e0264986. doi: 10.1371/journal.pone.0264986. eCollection 2022.
7
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.药物抑制 MEK 信号通路可阻止犬血管肉瘤生长。
Mol Cancer Ther. 2013 Sep;12(9):1701-14. doi: 10.1158/1535-7163.MCT-12-0893. Epub 2013 Jun 26.
8
Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets.犬血管肉瘤的分子特征及潜在的新型治疗靶点
Vet Sci. 2023 Jun 5;10(6):387. doi: 10.3390/vetsci10060387.
9
MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.微小RNA-214通过靶向COP1-p53轴促进犬血管肉瘤细胞凋亡。
PLoS One. 2015 Sep 3;10(9):e0137361. doi: 10.1371/journal.pone.0137361. eCollection 2015.
10
Tenovin-6 induces the SIRT-independent cell growth suppression and blocks autophagy flux in canine hemangiosarcoma cell lines.Tenovin-6 诱导犬血管肉瘤细胞系的 SIRT 非依赖性细胞生长抑制并阻断自噬流。
Exp Cell Res. 2020 Mar 1;388(1):111810. doi: 10.1016/j.yexcr.2019.111810. Epub 2019 Dec 28.

引用本文的文献

1
Genomic landscape and preclinical models of angiosarcoma.血管肉瘤的基因组图谱与临床前模型
Mol Oncol. 2025 Apr;19(4):965-983. doi: 10.1002/1878-0261.13744. Epub 2024 Oct 5.
2
Analysis of VEGFR-2 and PDGFR-β expression in canine splenic hemangiosarcoma to identify drug repositioning candidates.分析犬脾脏血管肉瘤中VEGFR-2和PDGFR-β的表达以确定药物重新定位的候选药物。
Braz J Vet Med. 2024 Aug 6;46:e001524. doi: 10.29374/2527-2179.bjvm001524. eCollection 2024.

本文引用的文献

1
Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).建立并鉴定首例患者来源的放射性诱导性血管肉瘤异种移植模型(RT-AS5)。
Sci Rep. 2023 Feb 14;13(1):2653. doi: 10.1038/s41598-023-29569-x.
2
Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy.依洛硫酸酯酶纳注射液:治疗脊髓性肌萎缩症的综述。
CNS Drugs. 2022 Sep;36(9):995-1005. doi: 10.1007/s40263-022-00941-1. Epub 2022 Aug 12.
3
The economics of moonshots: Value in rare disease drug development.登月计划的经济学:罕见病药物研发的价值
Clin Transl Sci. 2022 Apr;15(4):809-812. doi: 10.1111/cts.13270. Epub 2022 Mar 25.
4
Investigation of Prognostic Value of Claudin-5, PSMA, and Ki67 Expression in Canine Splenic Hemangiosarcoma.Claudin-5、PSMA和Ki67表达在犬脾脏血管肉瘤中的预后价值研究
Animals (Basel). 2021 Aug 14;11(8):2406. doi: 10.3390/ani11082406.
5
Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.比较犬和猫血管肉瘤的致癌基因组图谱显示出与人类血管肉瘤的新相似之处。
Dis Model Mech. 2021 Jul 1;14(7). doi: 10.1242/dmm.049044. Epub 2021 Jul 23.
6
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past.血管肉瘤的当前管理:最新进展与历史教训
Curr Treat Options Oncol. 2021 Jun 7;22(7):61. doi: 10.1007/s11864-021-00858-9.
7
A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs.一项针对犬 PD-1 治疗性抗体治疗犬晚期自发性癌症的临床前研究。
Sci Rep. 2020 Oct 27;10(1):18311. doi: 10.1038/s41598-020-75533-4.
8
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.帕博利珠单抗治疗的晚期实体瘤患者肿瘤突变负荷与结局的相关性:多队列、开放标签、Ⅱ期 KEYNOTE-158 研究的前瞻性生物标志物分析。
Lancet Oncol. 2020 Oct;21(10):1353-1365. doi: 10.1016/S1470-2045(20)30445-9. Epub 2020 Sep 10.
9
Neoadjuvant Systemic Treatment of Primary Angiosarcoma.原发性血管肉瘤的新辅助全身治疗
Cancers (Basel). 2020 Aug 12;12(8):2251. doi: 10.3390/cancers12082251.
10
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.针对肌萎缩性侧索硬化症的反义寡核苷酸 Tofersen 的 1-2 期临床试验。
N Engl J Med. 2020 Jul 9;383(2):109-119. doi: 10.1056/NEJMoa2003715.